The central aim of this administrative data analysis was to examine usage of a Web-based disease management program designed to provide continuing recovery support to patients discharged from residential drug and alcohol treatment. Tailored clinical content was delivered in a multimedia format over the course of 18 months posttreatment. The program also included access to a recovery coach across the 18 months. Consistent with other disease management programs, program usage decreased over time. A small subsample of patients accessed a large number of program modules in the year following treatment; these patients had significantly higher abstinence rates and consumed less alcohol than patients accessing few or no modules. Regression analyses revealed a significant relationship between the number of modules accessed and substance use outcomes in the year following treatment when controlling for motivation, self-efficacy, and pretreatment substance use. Limiting the analyses to only the more compliant patients did not reduce the magnitude of these effects. These preliminary results suggest that computerized support programs may be beneficial to patients recently treated for drug and alcohol issues. Methods to increase program engagement need additional study.
Introduction
The use of computerized disease management programs and other e-health interventions to treat and manage chronic health conditions has increased over recent years. Several research studies have examined participant usage of these programs and the extent to which usage is related to positive health behavior outcomes across a number of domains, including cancer (Gustafson et al., 2005) , diabetes (Glasgow et al., 2005; Williams, Lynch, & Glasgow, 2007) , heart disease (Verheijden et al., 2004) , and mood disorders (Farvolden, Denisoff, Selby, Bagby, & Rudy, 2005) . Overall, these studies suggest that computerized disease management programs can be effective, although rates of engagement are often low.
A number of computerized programs have been developed to address substance use and addictive disorders, with many focusing on alcohol abuse. Most of these programs provide screening and brief intervention, wherein participants provide information about alcohol and drug use and then receive clinical information, advice, and guidance on how to reduce use. A number of studies suggest that these programs are effective. For example, Hester, Squires, and Delaney (2005) developed the Drinker's Check-Up (DCU), a brief motivational intervention delivered over the computer in a series of modules. Modules focus on assessing drinking and alcohol-related problems, providing personalized feedback, and helping the participant resolve ambivalence about changing drinking. A recent study found that participants receiving DCU substantially reduced their alcohol use and other alcohol-related problems over a 12-month follow-up period (Hester et al., 2005) . Studies of other computerized screening and brief interventions have reported similar results (Cunningham, Humphreys, Kypri, & van Mierlo, 2006; Kypri, Langley, Saunders, Cashell-Smith, & Herbison, 2008) .
Other studies have shown that computerized versions of popular psychosocial treatment approaches are effective when administered to individuals having a substance use disorder. For example, Carroll et al. (2008) developed CBT4CBT, which supplemented therapist-delivered treatment with 8 weeks of biweekly access to a multimedia computer-based version of cognitive-behavior therapy (CBT). The first randomized controlled trial of this program focused on individuals with substance dependence attending outpatient treatment. Substance use outcomes were compared for two groups: one group received outpatient treatment plus the computerized version of CBT, and the other group received outpatient treatment as usual. The group receiving computerized CBT reported a greater number of abstinent days across the 8-week treatment period and had fewer positive drug screens compared with the treatment-as-usual group (Carroll et al., 2008) . A second report from this study examined substance use over a longer follow-up period (6 months) and produced similar findings (see Carroll et al., 2009) .
In a randomized controlled trial of opioid-dependent outpatients, Bickel, Buchhalter, Marsch, and Badger (2008) examined the efficacy of an interactive computerized behavioral treatment intervention based on contingency management and community reinforcement approaches (CRA). Patients receiving the computerized CRA treatment along with vouchers showed roughly the same number of weeks of continuous cocaine and opioid abstinence as patients receiving therapist-delivered CRA with vouchers, and both groups showed significantly longer periods of abstinence than a treatment-as-usual group. In a recent review of studies using computer-based treatment with individuals dependent on one or more illicit drugs, Moore, Fazzino, Garnet, Cutter, and Barry (2011) reported that most studies found better drug use outcomes for patients receiving computerized treatment than for control group patients not receiving the intervention. Patients also reported being highly satisfied with the computerized interventions and showed levels of treatment engagement and retention that were similar to therapist-provided treatments.
Although research generally supports the effectiveness of computerized prevention programs, such as screening and brief intervention, and computer-delivered treatment, very little is known about whether computer technology can be used to deliver continuing care and recovery support to individuals who have already received formalized treatment for a substance use disorder. To our knowledge, in contrast to other disorders such as heart disease and diabetes, no computerized continuing care programs have been developed for long-term management of substance use disorders despite a large body of research suggesting that traditional (noncomputerized) continuing care programs are associated with better posttreatment outcomes (McKay, 2009a) . A recent review of controlled continuing care studies found that interventions that were at least 12 months long or that included more active efforts to deliver the intervention components to patients were more likely to produce positive effects (McKay, 2009b) .
Most continuing care programs for substance use disorders, such as those discussed above, require participants to attend structured support groups and/or engage with counselors and other clinical staff over the telephone. It is currently unclear to what extent computerized programs can be used to deliver continuing care and recovery support to individuals treated for alcohol/drug dependence. Several years ago, Hazelden staff created My Ongoing Recovery Experience (MORE), a computerized recovery support program developed for patients receiving residential treatment for alcohol/drug dependence. Unlike other continuing care programs, the program delivers assessments, clinical content, resources, and activities over the computer. The program also involves periodic telephone and e-mail contact between patients and recovery coaches. This study had two goals: to examine usage of the MORE program after discharge from residential treatment and to assess the relationship between program usage and substance use outcomes during the year following treatment.
Materials and methods

The Hazelden MORE program
In 2006, Hazelden, a private nonprofit addiction treatment center, launched an innovative, first-of-its-kind computerized recovery support program called MORE. MORE was developed by licensed alcohol and drug counselors and mental health professionals for use with adult patients completing residential treatment for alcohol or drug dependence at Hazelden sites. Prior to implementation, patient input regarding program development was obtained through a number of focus groups. Feasibility of the program was tested by administering a sample of the program to several groups of patients who volunteered to be end users. Patients provided a number of recommendations regarding clinical content and program functionality that were incorporated into the final version of the program.
The program incorporates concepts and findings from a number of evidence-based treatment approaches, such as 12-step facilitation, motivational interviewing, and CBT. Through the program, patients have access to recoveryrelated information and services for a period of 18 months following discharge from treatment. MORE is an iteratively tailored, Web-based, mixed-media program that provides interactive recovery-related activities, videos, an extensive electronic library of content, opportunities for fellowship with other recovering individuals, and other sources of support. The videos cover a wide range of content, including patient testimonials and information on topics such as how to manage a co-occurring disorder, how to recognize factors that may lead to relapse, how to protect oneself from developing an addiction to prescription medications, and how to effectively manage stress. Other computerized resources include a patient journal, workbook activities for practicing and applying recently learned information, and an electronic library of articles pertaining to issues such as relapse prevention, dealing with cravings, and maintaining emotional health. Participants also have access to a network of Hazelden alumni and a number of resources for staying in contact with other individuals in recovery, such as recovery blogs, forums, podcasts, and online 12 step meetings.
The program is delivered in seven recovery "modules," each of which begins with an electronically administered assessment where patients provide detailed information about substance use and other aspects of life functioning. Based on the responses, the module then delivers content tailored to the individual needs of the patient. Patients receive modules in a sequential manner over an 18-month period, and modules have to be completed in order. In other words, content from later modules is only accessible if the participant accessed prior modules. In addition, the availability of the modules is timed across the 18-month period. The assessment for Module 1 is completed while patients are still in residential treatment, usually 1 week prior to discharge.
Each module focuses on specific issues that are likely to be experienced at that particular time in recovery. Table 1 provides a summary of each module and its key activities. Modules vary somewhat in length and range from 19 pages of content (Module 7) to 36 pages of content (Module 2). The total number of pages across all seven modules is 201.
In addition to the recovery modules and other computerized program components, another aspect of MORE pertains to recovery coaching. Each participant has a personal recovery coach, a licensed drug and alcohol counselor who provides ongoing support and guidance for a period of 18 months following treatment. Coaches maintain periodic contact with the patient both electronically and by telephone through a series of system "flags" or alert messages that indicate the patient has reached a milestone or is experiencing problems. When coaches receive a flag, they call the patient and discuss his or her current concerns. Patients who cannot be reached by telephone are sent an email message and asked to contact their coach. The frequency of coach-to-patient contact varies considerably, ranging from no contact at all to several times per month.
Participants
We examined a sample of residential patients who enrolled in the MORE program shortly before discharge; patients were discharged in the period from May 2006 to December 2007 . Only participants who met criteria for dependence on at least one substance were included in the sample; those who were classified as having abuse but not dependence were excluded. No other criteria were used to exclude patients from the sample. Table 2 summarizes demographic and baseline clinical characteristics of the sample. The average length of stay was 25.72 days (SD = 5.77), with 92% (n = 1,034) successfully completing treatment. Treatment completion was defined as attending the residential program for the period prescribed by clinical staff. The sample was 45% female, and the average age was 42.12 years (SD = 11.70 years). Forty six percent (n = 516) of the sample was married at the time of treatment admission, and 42% (n = 470) was employed full time. Ninety-six percent (n = 1,079) of patients were Caucasian. Please note that in this section and in later sections, the "n" represents the number of participants with a positive value for the relevant variable, not the total number in the sample.
Substance dependence and mental health diagnoses were made in the course of routine clinical operations through a comprehensive baseline assessment conducted by an interdisciplinary team of licensed alcohol and drug counselors, psychiatrists, and doctoral-level clinical psychologists. All diagnoses were based on the Diagnostic and Statistical Sober identity Establishing an identity as a sober individual, identifying and abandoning old thought patterns and beliefs, and exploring ways to continuously improve emotional and physical health. Module 7
Life goals Reexamining career, education, and life goals for long-term recovery.
Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria (American Psychiatric Association [DSM-IV-TR], 2000)
. Eighty-seven percent (n = 976) of the sample received a diagnosis of alcohol dependence. The percentage diagnosed as dependent on both alcohol and at least one other drug was 35% (n = 392). Sixty-five percent (n = 730) had a co-occurring mental disorder in addition to alcohol and/or drug dependence, with 35% (n = 393) having a depressive disorder. The average overall score on the Behavior and Symptom Identification Scale (BASIS-32) indicated a moderate level of impairment (1.45; SD = 0.73).
In addition to baseline data, patients completed follow-up surveys administered at roughly 6 and 12 months after discharge. Seventy percent of the sample (n = 786) completed the 6-month survey, 54% (n = 611) completed the 12-month survey, and 48% (n = 541) completed both surveys.
Measures
Measures collected at baseline
In the course of routine clinical operations, several surveys were administered to patients by counseling staff within several days of treatment admission. These surveys captured demographic information, frequency of substance use before treatment, and mental health characteristics.
2.3.1.1. Pretreatment alcohol and drug use. Several questions from the modified Form 90 (Project MATCH Research Group, 1993) were used to assess alcohol and drug use during the 90 days prior to treatment admission. Alcohol use items included the number of days the patient had at least one alcoholic drink (drinking days), the average number of drinks consumed on drinking days (drinks per drinking day), and the number of days the patient used each of several recreational drugs, as a function of drug type (e.g., marijuana, cocaine, heroin). The Form 90 has been used with adolescents and adults with substance use disorders and has demonstrated good validity and test-retest reliability (Tonigan, Miller, & Brown, 1997) .
2.3.1.2. Pretreatment 12-step involvement. Several questions from the Alcoholics Anonymous Affiliation Scale (AAAS; Humphreys, Kaskutas, & Weisner, 1998) measured 12-step group involvement during the year prior to treatment admission. Patients were asked how many 12-step meetings they had attended during the period and how many of the steps they had "worked." They were also asked the following yes/no questions: whether they had attended AA (or a related group), whether they considered themselves to be a member of AA, whether they had celebrated a sobriety birthday, whether they had a sponsor, whether they had ever been a sponsor, and whether they had ever experienced a spiritual awakening. The number of yes responses to these questions was summed to comprise the "AA composite" score, which served as a quantitative measure of AA involvement separate from meeting attendance (see Witbrodt & Kaskutas, 2005) . The AAAS has been shown to have high reliability and validity (Humphreys et al., 1998) .
2.3.1.3. Behavior and Symptom Identification Scale (BASIS-32). The BASIS-32 is a global measure of psychological functioning and was administered within the first week of treatment. It consists of 32 questions that assess five aspects of mental health: relation to self and others, daily living and role functioning, depression and anxiety, impulsiveness, and psychosis. Participants are given 32 items that list various domains of functioning (e.g., "adjusting to major life stresses") and are asked to rate how much difficulty they experienced in that area during the past week. Higher scores represent greater problem severity. The BASIS-32 has been used with adolescents and adults and has demonstrated acceptable levels of internal consistency, test-retest reliability, and concurrent validity (Eisen, Dill, & Grob, 1994) . 
Measures collected within the MORE program
Several questions were administered within the assessment for Module 1 of the MORE program. This assessment was completed by patients over the computer roughly 1 week before treatment discharge.
2.3.3.1. Number of people in the support network. Module 1 asks a question regarding the patient's support network: "Currently, who are the main people you rely on for support?" It then lists a number of possible responses (e.g., wife, husband, father, daughter). A variable was created for each patient by summing together the total number of people identified.
2.3.3.2. Self-efficacy and motivation. The question for selfefficacy asked, "How confident do you feel in your ability to work an active recovery program at this time?" (response scale: 1 = not confident at all to 7 = extremely confident). The question for motivation asked, "How motivated do you feel in your ability to work an active recovery program at this time?" (response scale: 1 = not motivated at all to 7 = extremely motivated).
Measures collected at follow-up
A follow-up survey, used in the course of routine health care operations, contained questions about behaviors and events that occurred in the period since discharge; only those questions germane to the present evaluation will be discussed here. Patients completed the follow-up survey at three different times postdischarge: 1 month (25-44 days), 6 months (173-210 days), and 12 months (358-395 days). Questions referred to the period since treatment discharge or since the last follow-up survey date if one was completed. It is important to note that we did not analyze any 1-month followup data because these data showed extremely low variability; with more than 85% of patients reporting no substance use during the period. However, any substance use data reported at the 1-month follow-up was accounted for in later follow-ups.
The substance use questions came from the modified Form 90 (Project MATCH Research Group, 1993) and were the same as those asked at baseline (discussed above). These questions and all others were asked to the patient over the telephone by research department outcomes evaluation staff extensively trained to conduct follow-up interviews. The 12-step involvement questions were also the same as those asked at baseline except they referred to behaviors during the follow-up period. Another question asked the patient if he or she had attended any other formal alcohol/drug treatment during the follow-up period.
Each follow-up also consisted of several questions designed to measure satisfaction with the MORE program. These questions were asked to each patient who indicated that he or she had used MORE at least once since discharge from treatment. One question asked patients to rate the overall quality of the MORE program (on a scale of excellent, very good, good, fair, and poor). Other questions asked patients to indicate their perception of how useful the program was to their recovery, for example, "The content of the MORE program has been relevant to my recovery" and "I have begun working a recovery program because of MORE" (both questions used a scale of strongly agree, agree, neutral, disagree, and strongly disagree).
2.3.5. Outcomes measures 2.3.5.1. MORE usage: Number of modules accessed. Each of the seven modules within MORE has a tailor date or the date that a participant first accesses the module assessment. The total number of module tailor dates for each participant was summed together to create a variable called "number of modules accessed." This variable served as the primary measure of program use. In addition to serving as a secondary outcomes measure, number of modules touched was also used as a predictor in regression analyses for substance use outcomes.
Continuous abstinence.
A patient was counted as continuously abstinent at each follow-up if he or she reported no alcohol or illicit drug use during the period since discharge. The percentage of patients continuously abstinent was calculated for the 6-and 12-month follow-ups.
2.3.5.3. Percent days abstinent from alcohol. At each follow-up assessment, patients indicated how many days they consumed alcohol during the period referenced by the assessment. This number was then subtracted from the total number of days in the assessment period to get the number of abstinent days from alcohol. This number was then divided by the total number of days in the period and multiplied by 100 to obtain the percent days abstinent (PDA) from alcohol. PDA from alcohol at the 6-and 12-month follow-ups took into account the number of abstinent days reported at previously completed evaluations. Although it was possible to calculate PDA for each illicit drug, we could not calculate overall PDA from both alcohol and drugs because use days for different substances often overlapped. Therefore, given that 87% of patients were alcohol dependent, we focused our analyses on PDA from alcohol.
Analysis strategy
The first set of analyses examined module usage within the MORE program, as indicated by the percentage of patients accessing a given module at least one time. We also created a variable that represented the overall level of module use for each participant.
In the second series of analyses, we classified participants into one of two groups based on module usage. The first group was called the "highly adherent" group and consisted of participants who accessed at least six of the seven program modules at least once during the year following discharge. The second group was called the "less adherent" group and consisted of participants who accessed five or fewer modules in the year following discharge. A cutoff of five modules was chosen for several reasons. Dividing the sample using seven modules as the criterion resulted in a very small number of highly adherent users (less than 6% of patients). However, it was still deemed clinically important to use a fairly stringent definition of highly adherent use, as the MORE program was designed to deliver six of the seven modules within 1 year of leaving treatment. Highly adherent and less-adherent module users were compared on substance use outcomes at 6 and 12 months postreatment via a series of bivariate tests.
Generalized estimating equations (GEE) and mixedmodel regression analyses were then conducted to further examine the relationship between module use and substance use outcomes at 6 and 12 months postdischarge. GEE and mixed effects models have advantages over conventional repeated-measures methods in that they allow for missing observations, accommodate measurements made at different time points, provide greater flexibility in modeling the variance-covariance matrix, and permit the estimation of both group and random subject-specific effects (Diggle, Heagerty, Liang, & Zeger, 2002) . The current analysis assumes a compound symmetry structure, as we only have two levels of the repeated-measures factor (i.e., Month 6 and Month 12). The compound symmetry assumption can only be violated when the repeated-measures factor has more than two levels. A separate model was produced for each of two outcomes: the percentage of patients who were continuously abstinent from alcohol and drugs at follow-up and the percentage of days abstinent from alcohol at follow-up. The number of modules accessed and the time of follow-up (6 vs. 12 months) were entered as predictors. In addition, all other variables listed in the Measures section were included in the models as covariates. Although there was a substantial number of missing assessments, we ran the models on the existing data and did not impute missing data. Continuous abstinence status was only calculated if the appropriate substance use data were available; we did not count participants who were lost to follow-up as relapsed.
As a last step, the regression analyses outlined above were conducted only on patients who were deemed to be in compliance with continuing care recommendations. These analyses explored the possibility that patients accessing a large number of MORE modules may also be engaging in other prescribed recovery behaviors, such as following through with their continuing care plans and engaging with 12-step fellowships. These patients would be expected to have better substance use outcomes, therefore making it unclear whether outcomes are due to compliance in general rather than to module use specifically. To address this possibility, we identified a subsample of compliant patients and reran the regression models on this group. A patient was labeled compliant if he or she met all of the following criteria at the time of the 1-month follow-up: (a) reported following most, some, or a few of their continuing care plan recommendations; (b) had an AA composite score of 2 or greater; and (c) attended at least two AA or 12-step meetings a week. Table 3 shows the percentage of patients in the sample who accessed each of the seven program modules. As expected, engagement was highest for Module 1, which was accessed while patients were in treatment. Eighty-four percent (n = 943) of discharges accessed this module at least once. It is important to note that although Module 1 was available to all patients and they were encouraged by clinical staff to log onto the module, some patients opted to not log on. All patients received an introduction to MORE and were briefly trained on how to use the program, but logging onto Module 1 was not required as a part of training. It is unknown why some patients opted to not log onto Module 1 while in treatment. Another key finding was that module engagement steadily decreased over time (postdischarge), with 25% (n = 285) accessing Module 3 and 5% (n = 58) accessing Module 7 (the final module).
Results
Module engagement
Another way to examine module engagement is to sum up the number of modules accessed by each patient and determine how many patients accessed a given number of modules. The mean number of modules accessed was 1.75 (SD = 2.09). Forty-four percent (n = 489) of the sample accessed Module 1 only (i.e., they did not access any modules beyond Module 1), and 5% (n = 58) of patients accessed all seven modules.
Substance use outcomes of highly adherent versus less-adherent module users: Results of bivariate tests
Regarding continuous abstinence rates, highly adherent users had significantly higher rates than less-adherent users Another way to examine the relationship between module use and outcomes is to identify patients who accessed one or more modules after treatment discharge and compare their outcomes to patients who do not access any modules after treatment. Because Module 1 was the only module accessed during the treatment stay; posttreatment module use was defined as access of Module 2 or beyond. Forty percent (n = 454) of the sample had posttreatment module use; the remaining 60% (n = 668) only accessed Module 1 (or no modules at all).
Regarding continuous abstinence at 6 months, the posttreatment module use group had a significantly higher abstinence rate (62%, n = 239) than the group that did not access the modules after treatment (53%, n = 248), p b .01. For continuous abstinence at 12 months, the difference between the two groups approached significance (56% vs. 49%, p = .08). For PDA from alcohol at 6 months, the posttreatment use group was significantly higher (97%, n = 381) than the other group (94%, n = 468), p b .01. The difference between the two groups for PDA at 12 months was also significant (97% vs. 95%, p b .05).
Mixed-model regression analyses
Mixed-model regression analyses examined the relationship between number of modules accessed and two outcome variables: (a) continuous abstinence (binary) and (b) PDA from alcohol (continuous). The outcome measures were assessed at Month 6 and Month 12. GEE (Diggle et al., 2002) analyses were used for the binary outcome, and linear mixed-effects models (Littell, Milliken, Stroup, & Wolfinger, 1996) were used for the continuous outcome. The models included terms for total number of modules accessed, time of follow-up (6 vs. 12 months), and the Module × Time interaction and specified an exchangeable (GEE) or compound symmetry (linear mixed effects) covariance structure. In addition, the models included the following covariates: self-efficacy and motivation at the Module 1 assessment, attended formal alcohol/drug treatment during the 1-month follow-up, total number of people in the support network, number of pretreatment drinking days, the AA composite score at the 1-month follow-up, and presence of a co-occurring disorder. A total of 1,122 participants were included in the analyses.
Results of GEE for continuous abstinence
The GEE analysis revealed a significant effect of the number of modules accessed, χ 2 (1) = 18.17, p b .001, with the likelihood of abstinence increasing as the number of modules increased (odds ratio [OR] = 1.18, 95% confidence interval [CI] = 1.10-1.28). In addition, there was a significant effect of time, χ 2 (1) = 17.07, p b .001, with higher rates of abstinence in Month 6 than Month 12 (OR = 1.50, 95% CI = 1.25-1.80). The interaction did not approach statistical significance (p = .24). Significant covariates in the model included self-efficacy, χ 2 (1) = 6.44, p = .01, and cooccurring disorder, χ 2 (1) = 5.81, p = .01, with a higher likelihood of abstinence associated with increases in selfefficacy (OR = 1.31, 95% CI = 1.07-1.61) and a higher likelihood of not having a co-occurring disorder (OR = 1.52, 95% CI = 1.08-2.13).
Results of mixed effect models for PDA from alcohol
The results from the mixed-effects model for PDA indicated that the number of modules accessed was a significant predictor of PDA, F(1, 602) = 10.25, p = .001. Time and the Module × Time interaction were not statistically significant (p b .70 and p b .35, respectively). Significant covariates in the model included self-efficacy, F (1, 602) = 4.02, p = .045, number of people in the support network, F(1, 602) = 4.44, p = .035, and number of pretreatment drinking days, F(1, 602) = 18.32, p b .001. Self-efficacy and number in the support network were positively related to PDA from alcohol, and number of pretreatment drinking days was negatively related to PDA from alcohol.
Regression analyses of compliant patients
The same regression models reported above were conducted on 483 patients who met the definition of being compliant (as defined in the Materials and methods section) with one modification: If a predictor in the original model was one of the variables used to determine compliance, then it was dropped from the compliant patient model. These analyses were conducted to determine if the number of modules accessed continued to predict 6-and 12-month outcomes in the compliant patient models. The GEE for continuous abstinence revealed a significant effect of modules accessed, χ 2 (1) = 6.38, p = .01, with the likelihood of abstinence increasing with the number of modules (OR = 1.16, 95% CI = 1.04-1.29). There was also a significant effect of time, χ 2 (1) = 10.09, p = .001, with a greater likelihood of abstinence at Month 6 than at Month 12 (OR = 1.57, 95% CI = 1.21-2.03). The Module × Time interaction was not statistically significant (p b .27). The mixed-effects model for PDA from alcohol indicated that the number of modules accessed was a significant predictor of PDA, F(1, 324) = 4.39, p = .04. There was also a significant effect of time, F(1, 211) = 4.61, p = .03, and the Module × Time interaction approached significance, F(1, 211) = 3.56, p = .06. In addition, the covariate of pretreatment drinking days was a significant predictor, F(1, 324) = 8.61, p = .004, with a lower number of pretreatment drinking days associated with a higher PDA.
Satisfaction with the MORE program
On each follow-up survey, several questions asked patients who indicated using the MORE program after treatment discharge to rate their satisfaction with various aspects of the program. Of the 454 patients (40% of the sample) who were using the program during the follow-up period, more than 70% rated the program as very good or excellent. More than 80% stated that they agreed or strongly agreed with the statement "The content of the MORE program has been relevant to my recovery," and 64% stated that they agreed or strongly agreed with the statement "I have begun working a recovery program because of MORE."
Discussion
The present analysis examined usage of the MORE program, an innovative, computerized recovery support program for patients who recently completed residential treatment for alcohol or drug dependence. The program is available during the first 18 months after discharge from treatment. The first component of the program involves a series of modules and other resources and activities delivered in a mixed-media format over the computer. In addition, each patient has contact with a recovery coach, a licensed drug and alcohol counselor. The results of the present analysis suggest a positive relationship between use of the program modules and posttreatment outcomes. Patients who accessed a large number of modules during the 12-month follow-up period were significantly more likely to be abstinent and had a higher percentage of days abstinent from alcohol than patients who accessed few or no modules. In addition, regression analyses revealed that number of modules accessed was a significant predictor of substance use outcomes during the 12 months following treatment, even when accounting for other covariates such as motivation, self-efficacy, and pretreatment substance use.
Although a relationship was found between MORE use and outcomes, it is unclear whether the relationship is causal. It is possible that patients who are very compliant with all of their continuing care recommendations (only one of which is using MORE) have better outcomes than noncompliant patients. Overall, the regression analyses conducted on "compliant" patients revealed an effect for MORE program use that was about the same magnitude as that observed in the full sample, but findings should be considered preliminary until they are replicated with a stronger design such as a randomized controlled trial. It is also important to note that this analysis was based on administrative data collected in the course of standard clinical operations. A randomized controlled trial comparing outcomes of MORE participants with outcomes of participants not using the program is the only way to determine program efficacy.
This analysis also revealed that a substantial number of patients were not using the program as recommended.
More than 80% of patients accessed Module 1 at least once, but this is not surprising given that patients access this module while still in treatment. In contrast, less than half of patients accessed Module 2, which is available roughly 1 month following discharge, with access decreasing steadily across subsequent modules. However, it is important to note that many patients did use MORE after leaving treatment, and a small number of these patients accessed at least five of the seven modules, indicating some long-term use of the program during the year following treatment. Regarding satisfaction with the MORE program, most of the patients rated the overall quality of the program as excellent, although 30% of patients did not give it a high rating. This result combined with the relatively low levels of engagement suggests that modifications to implementation efforts or to the program itself may be in order. Future research should focus on increasing the acceptability and feasibility of the program. Methods to increase engagement, such as providing patients with incentives, incorporating module use directly into the residential treatment plan, or increasing the frequency and duration of contacts between each patient and his or her recovery coach, should be further explored.
It is important to note that low levels of patient engagement are not unique to MORE, and several studies have reported low engagement with other Web-based addiction programs. Strecher et al. (2008) examined a behavioral Web-based smoking cessation program in two samples of HMO members who were attempting to quit smoking. Similar to MORE, the program consisted of distinct sections available over a period of time that delivered tailored messaging and feedback to participants based on their responses. On average, participants accessed 2.5 sections during the period. These numbers are similar to the mean number of program modules accessed in this study, which was 1.75. Another study examined Quit Smoking Now, a Web-based program providing smoking cessation information and guidance on behavior change strategies (McKay, Danaher, Seeley, Lichtenstein & Gau, 2008) . The average number of program visits during a 6-month period was 2.14, and more than 90% of participants had completely stopped using the program by 6 months postenrollment. In summary, low levels of patient engagement with Web-based, computerized health behavior change programs continue to present clinical and methodological challenges.
Although no published studies to date have examined computerized continuing care programs, a large number of studies have examined patient engagement with more traditional programs. Similar to the engagement results with MORE reported here, these studies indicate that client engagement and retention are an issue with traditional continuing care programs. Cacciola et al. (2008) conducted a study of a telephone-based continuing care protocol recently implemented at the Betty Ford Center. This program, called Focused Continuing Care, is offered to all patients who have completed residential treatment and involves several brief telephone-counseling sessions between patients and clinical staff. These calls are scheduled to take place at predetermined periods after discharge from treatment. A key finding was that although 71% of patients in the sample completed the first call, only 28% completed the last call (which took place roughly a year after discharge). By 6 months postdischarge, less than 40% of patients completed any given call, and less than 1% completed all 14 calls of the program. The 1% call completion rate is similar to the module completion rate found for the MORE program, which was 5%. Lash et al. (2007) conducted a randomized clinical trial to determine the effectiveness of a continuing care program for patients attending residential treatment through the VA. The program consisted of three processes: (1) clients signed a written contract prior to leaving treatment whereby they agreed to attend continuing care sessions, (2) clients received attendance prompts prior to each scheduled session, and (3) clients were positively reinforced for attendance. Even when patients were explicitly reminded to attend their continuing care sessions and were positively reinforced for doing so, attendance decreased substantially over time, with only 40% attending sessions on a monthly basis throughout the follow-up period. These studies as a whole suggest a number of challenges in keeping patients engaged in continuing care programs over time.
A large number of studies have also examined the extent to which traditional continuing care programs enhance treatment outcomes. Similar to our finding that patients who were highly engaged with MORE had better substance use outcomes, several studies have found continuing care programs to be effective for patients who engage with these programs. It is important to note that these studies provide much stronger support than this study because many were randomized controlled trials that compared patients receiving the program with a control group of patients who did not receive the program. In the study by Lash et al. (2007) described above, clients who participated in the continuing care program were significantly more likely to be abstinent 1 year following treatment than clients in the treatment-asusual condition. McKay (2005) examined clients attending a 4-week intensive outpatient program through either the VA or their community. Clients in the continuing care condition received brief telephone counseling sessions combined with several group support sessions; these patients were compared with those who received relapse prevention or 12-steporiented group counseling. Continuing care clients had significantly higher abstinence rates in the 2 years following treatment than the other two groups. Several other studies have reported similar findings (for a review, see McKay, 2009a McKay, , 2009b .
Several limitations should be considered when interpreting the administrative data reported here. Although the follow-up rate at 6 months was 70%, only 54% of the sample was contacted at12 months. The low end point follow-up rate raises concerns about potential sample bias. Another issue pertaining to generalizability concerns findings for PDA from alcohol during the 6-and 12-month follow-up periods. PDA was extremely high (i.e., greater than 93%) even at 12 months. These data suggest that patients who are relapsing to alcohol use are not doing so for a long period. Potential explanations for this include underreporting of substance use or that a disproportionate number of patients with highly favorable outcomes were reached at follow-up. In any case, the relative lack of variability in this outcome reduced the likelihood of finding significant relationships between module use and frequency of abstinent days.
The analyses reported here focused on one aspect of MORE usage, which was the total number of modules accessed by each participant. This measure was the only one available at the time, so we could not report other measures such as number of program logins or number of visits to components other than the modules. On a further methodological note, the measure of self-efficacy used here differed somewhat from measures used in other studies. Self-efficacy is typically referred to as confidence in one's "ability to stay sober"; in the MORE program, it is phrased in terms of confidence in one's "ability to work a recovery program."
Despite limitations inherent with administrative data sets, these analyses have several strengths. This is the first evaluation we are aware of to examine usage of a unique and innovative Web-based continuing care program for patients with alcohol or drug dependence. The results provide support for a positive relationship between use of the MORE program and substance use outcomes after treatment and suggest that computerized programs may hold promise as continuing care interventions. This study also used both bivariate tests and mixed-model regression analyses to explore the relationship between program use and outcomes and conducted analyses on compliant patients to account for the possibility that the relationship between MORE use and outcomes merely reflected a relationship between outcomes and compliant behavior in general. Future evaluations will further examine how usage impacts outcomes and how program engagement can be increased.
